{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:35:03Z","timestamp":1793061303834,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jacasi.2026.08.014","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:59:10Z","timestamp":1791316750000},"page":"2374-2377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Real-World Research in Cardio-Oncology"],"prefix":"10.1016","volume":"6","author":[{"given":"Koohyar","family":"Ahmadzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Heidari Meybodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacasi.2026.08.014_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: towards achieving the achievable in cancer care","volume":"16","author":"Booth","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jacasi.2026.08.014_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00270-025-04179-4","article-title":"Real-world evidence: better than nothing or the future? A perspective on clinical evidence generation in interventional oncology","volume":"49","author":"Kaufmann","year":"2026","journal-title":"Cardiovasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.jacasi.2026.08.014_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/a-2664-7887","article-title":"Comparative effectiveness research using randomized trials and observational studies: validity and feasibility considerations","volume":"126","author":"Bikdeli","year":"2026","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.jacasi.2026.08.014_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1055\/a-2316-5269","article-title":"Edoxaban, rivaroxaban, or apixaban for cancer-associated venous thromboembolism in the real world: insights from the COMMAND VTE registry-2","volume":"124","author":"Sueta","year":"2024","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jacasi.2026.08.014_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/a-2347-4338","article-title":"Risk of major bleeding with antiplatelet and\/or anticoagulation therapy in inherited factor XI deficiency: insights from real-world observations","volume":"125","author":"Vaismann","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacasi.2026.08.014_bib6","article-title":"Impact of atrial fibrillation on thrombotic complications in myeloproliferative neoplasms real-world analysis","author":"Demska","year":"2026","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jacasi.2026.08.014_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaccao.2024.09.014","article-title":"Cardiovascular safety in oncology clinical trials: JACC: cardiooncology primer","volume":"7","author":"Bonaca","year":"2025","journal-title":"JACC CardioOncol"},{"issue":"1","key":"10.1016\/j.jacasi.2026.08.014_bib8","first-page":"13","article-title":"Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports","volume":"8","author":"Ewer","year":"2022","journal-title":"Cardiooncology"},{"issue":"10","key":"10.1016\/j.jacasi.2026.08.014_bib9","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacasi.2026.07.019","article-title":"Oncologic benefits and cardiovascular risks of pembrolizumab: insights from a nationwide lung adenocarcinoma cohort","volume":"6","author":"Park","year":"2026","journal-title":"JACC Asia"},{"issue":"9","key":"10.1016\/j.jacasi.2026.08.014_bib10","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.clon.2019.05.003","article-title":"Generalisability of common oncology clinical trial eligibility criteria in the real world","volume":"31","author":"Karim","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1016\/j.jacasi.2026.08.014_bib11","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.jacasi.2026.08.014_bib12","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.3390\/jcm13237492","article-title":"Differential cardiotoxicity of ibrutinib versus chemoimmunotherapy in chronic lymphocytic leukemia: a population-based study","volume":"13","author":"Majrashi","year":"2024","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.jacasi.2026.08.014_bib13","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1080\/10428194.2026.2653123","article-title":"Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors: a propensity matched analysis","volume":"67","author":"Majrashi","year":"2026","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jacasi.2026.08.014_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijrobp.2019.07.056","article-title":"Immortal time bias in national cancer database studies","volume":"106","author":"Newman","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.jacasi.2026.08.014_bib15","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1158\/1055-9965.EPI-22-0495","article-title":"The timing, the treatment, the question: Comparison of epidemiologic approaches to minimize immortal time bias in real-world data using a surgical oncology example","volume":"31","author":"Duchesneau","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.jacasi.2026.08.014_bib16","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2025-0186","article-title":"Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?","volume":"15","author":"Bermejo","year":"2026","journal-title":"J Comp Eff Res"},{"issue":"3","key":"10.1016\/j.jacasi.2026.08.014_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.jacasi.2026.08.014_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/cer-2020-0013","article-title":"Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants","volume":"9","author":"Allan","year":"2020","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jacasi.2026.08.014_bib19","article-title":"Competing risks data in clinical oncology","volume":"14","author":"Kim","year":"2024","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.jacasi.2026.08.014_bib20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1200\/JCO-25-01906","article-title":"Target trial emulation for regulatory and clinical decision making in cancer","volume":"44","author":"Dickerman","year":"2026","journal-title":"J Clin Oncol"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726007143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726007143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:21:35Z","timestamp":1793060495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374726007143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2772374726007143"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.08.014","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Research in Cardio-Oncology","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.07.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}